ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Amarantus Bioscience Holdings Inc (EM)

Amarantus Bioscience Holdings Inc (EM) (AMBS)

0.000001
0.00
(0.00%)
終了 7月2日 5:00AM

Amarantus Bioscience Holdings Inc (EM) (AMBS) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
0.000001
( - )
買値
0.00
売値
0.00
出来高
-
0.00 日の範囲 0.00
0.000001 52 週間の範囲 0.25
時価総額
前日終値
0.000001
始値
-
時刻
最終取引時間
-
財務取引量
-
VWAP
-
平均取引量 (3 か月)
US$ 1,070,161
発行済株式数
630,407,411
配当利回り
PER
-0
1 株当たり利益 (EPS)
-0.03
歳入
-
純利益
-7.94M

Amarantus Bioscience Holdings Inc (EM) について

Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. The company’s diagnostic products in development include the lymphocyte proli... Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. The company’s diagnostic products in development include the lymphocyte proliferation (LymPro) test, a diagnostic blood test for Alzheimer’s disease; and MSPrecise, a proprietary DNA sequencing assay for the identification of patients with multiple sclerosis. Its therapeutic products in development comprise Eltoprazine, a small molecule drug for the treatment of Parkinson’s disease Levadopa-Induced Dyskinesia and attention deficit hyperactivity disorders; and mesencephalic-astrocyte-derived neurotrophic factor for the treatment of various animal models, including retinitis pigmentosa and retinal artery occlusion. It also develops NuroPro, a neurodegenerative disease diagnostic platform with application in Parkinson’s disease; BC-SeraPro, an oncology diagnostic platform with application in breast cancer; and PhenoGuard platform for neurrotrophic factor discovery. In addition, the company develops Engineered Skin Substitute (ESS), a cell therapy-based autologous skin replacement product that is in mid-stage clinical development for the treatment of life-threatening severe burns. Amarantus BioScience Holdings, Inc. has a cooperative research and development agreement with the U.S. Army Institute of Surgical Research and Rutgers University. The company was formerly known as Amarantus Bioscience, Inc. and changed its name to Amarantus BioScience Holdings, Inc. in April 2013. Amarantus BioScience Holdings, Inc. was founded in 2008 and is headquartered in New York, New York. 詳細を表示

セクター
Finance
業界
Asset Management Services
ウェブサイト
本社
New York, United States
設立
2026
Amarantus Bioscience Holdings Inc (EM) is listed in the Finance sector of the その他OTC with ticker AMBS. The last closing price for Amarantus Bioscience (EM) was US$0. Over the last year, Amarantus Bioscience (EM) shares have traded in a share price range of US$ 0.000001 to US$ 0.25.

Amarantus Bioscience (EM) currently has 630,407,411 shares in issue. The market capitalisation of Amarantus Bioscience (EM) is US$630.41 . Amarantus Bioscience (EM) has a price to earnings ratio (PE ratio) of -0.00.

AMBS 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
4001.0E-61.0E-61.0E-6259031.0E-6CS
12001.0E-60.251.0E-69967795.37E-6CS
26001.0E-60.251.0E-66567284.83E-6CS
52001.0E-60.251.0E-64114911.257E-5CS
156-0.000749-99.86666666670.000750.251.0E-66815400.00068495CS
260-0.008599-99.9883720930.00860.251.0E-616352770.00441398CS

AMBS - Frequently Asked Questions (FAQ)

What is the current Amarantus Bioscience Holdings Inc (EM) share price?
The current share price of Amarantus Bioscience Holdings Inc (EM) is US$ 0.000001
How many Amarantus Bioscience Holdings Inc (EM) shares are in issue?
Amarantus Bioscience Holdings Inc (EM) has 630,407,411 shares in issue
What is the market cap of Amarantus Bioscience Holdings Inc (EM)?
The market capitalisation of Amarantus Bioscience Holdings Inc (EM) is USD 630.41
What is the 1 year trading range for Amarantus Bioscience Holdings Inc (EM) share price?
Amarantus Bioscience Holdings Inc (EM) has traded in the range of US$ 0.000001 to US$ 0.25 during the past year
What is the PE ratio of Amarantus Bioscience Holdings Inc (EM)?
The price to earnings ratio of Amarantus Bioscience Holdings Inc (EM) is -0
What is the registered address of Amarantus Bioscience Holdings Inc (EM)?
The registered address for Amarantus Bioscience Holdings Inc (EM) is 45 Wall Street, New York, New York, 10005
What is the Amarantus Bioscience Holdings Inc (EM) website address?
The website address for Amarantus Bioscience Holdings Inc (EM) is www.amarantus.com
Which industry sector does Amarantus Bioscience Holdings Inc (EM) operate in?
Amarantus Bioscience Holdings Inc (EM) operates in the Asset Management Services sector

AMBS 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

AMBS Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock